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37.76% and 11.31%. From 2010 to 2012, the average hospitalization expenses of 
each visit with BMISE was 25575.34, 24219.22 and 26889.57 yuan; For BMISUR, the 
expenses of each visit was 21211.57, 18999.53 and 19088.96 yuan. Reimbursement by 
BMISE in 2010, 2011 and 2012 was 71.01%, 74.12% and 68.25%; while the reimburse-
ment by BMISUR was 45.95%, 53.49% and 51.16%. ConClusions: The insurance 
level difference between two health insurance schemes influences the treatment 
regimens and benefits received by patients. People prefer to go to third-level hospi-
tals, but people with BMISE has higher proportion than people with BMISUR, about 
10%. For the people with BMISUR, the out-of-pocket spending was 50% of total 
expenses, needing to raise reimbursement rate, setting up differentiated reimburse-
ment for different income level groups. From 2011 to 2012, the reimbursement rate 
declined slowly, we need to study the cause in the future.
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objeCtives: According to Canada, US and European guidelines and the Helsingborg 
Declaration, all eligible stroke patients should receive care in specialized stroke 
centers. During the last decade, partly due to the Alberta Provincial Stroke Strategy 
(APSS), 16 stroke centers were established in Alberta. This study examined the effect 
of admission to stroke centers on mortality for patients with ischemic stroke, com-
pared with admission to non-stroke centers. Methods: The study population was 
identified from the Discharge Abstract Database (DAD) from the province of Alberta, 
Canada. We included stoke patients with most response diagnostic code I63 (ICD10) 
with a first admission to acute care hospitals between April 1st 2004 and March 
31st 2011. Disease specific co-morbidities were adapted from the literature review, 
including secondary diagnoses in the DAD. We utilized the triage information from 
National Ambulatory Care Report System (NACRS) as the proxy of disease severity. 
The average marginal effect of stroke center on the 30-days in-hospital mortality 
was estimated in a bivariate probit model, using differential distance to hospitals as 
an instrumental variable to correct potential pre-hospital selection bias, adjusting 
for age, sex, co-morbidities, and disease severity. Results: Among 9152 patients, 
6405 (70%) were admitted to stroke centers (n= 16) and 2747 (30%) to non-stroke 
centers. The overall unadjusted 30-day all-cause mortality rate was 9.8% for patients 
first admitted to stroke centers and 11.1% for patients admitted to non-designated 
hospitals. Adjusting patient characteristics and other factors, we found first admis-
sion to a stroke center was associated with a 6.4% (95%CI: -1.2%, -11.5%) absolute 
reduction in 30-day all-cause in-hospital mortality compared to non-stroke cent-
ers. ConClusions: In an observational study, we provided new evidence to sup-
port the role of stroke center on the reduction in mortality in a universal publicly 
funded health care system.
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objeCtives: Although previous studies have shown that stroke centers reduce 
mortality in patients with ischemic stroke, the association between stroke cent-
ers and reduction in length of stay (LOS) in hospital has not been demonstrated. 
We sought to evaluate the impact of stroke centres as designated by the Alberta 
Provincial Stroke Strategy (APSS) in Alberta on the LOS of acute ischemic stroke 
patients. Methods: We compared the actual LOS during the first episode of hos-
pitalization for patients with acute ischemic stroke admitted first to designated 
stroke centers or non-stroke centers between April 1st 2004 and March 31st 2011 
using the Alberta Hospital Discharge Abstracts Database. Using propensity score 
methods, we applied a log linear regression model to estimate the average change 
in LOS for all ischemic patients and the change for the patients admitted to the 
stroke centers, adjusting for age, sex, co-morbidities, disease severity, discharge 
type and being in the alternate level of care. Results: Among 9,092 patients, 6,360 
(70%) were admitted to stroke centers. The prolonged hospital stay with alternate 
level of care designation had occurred in 1,572 (17.3%) of patients. The number of 
patients discharged to home, home with support or other health care facility, or 
died were 3,767(41.4%) 4,159(45.7%), and 1,166 (12.8%), respectively. The average 
unadjusted LOS was 21.3 (SD= 33.9) days for patients admitted to stroke centers 
and 24.8 (SD= 37.5) days for patients admitted to non-stroke centers. Adjusting 
for the patient characteristics and other factors, we estimated that the average 
LOS was reduced by 6.5% (95%CI: -12.3%, -0.6%) for patients first admitted to 
stroke centers compared with non-stroke centers. ConClusions: The study 
shows that in patients with acute ischemic stroke, first admission to stroke cent-
ers had significantly reduced LOS compared with non-stroke centers in Alberta 
by about 1.4 days.
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objeCtives: Medicaid coverage among non-elderly adults is often characterized by 
drop-outs and churning – entering and exiting Medicaid – over short durations. Little 
is known about the impact of such disruptions in Medicaid coverage on health care 
resources utilization and adherence to cardiovascular and lipid-lowering medica-
tions among enrollees with cardiovascular disease (CVD). Methods: This was a 
retrospective, repeated cross-sectional study design employing data from 2002-2011 
Medical Expenditure Panel Survey. Study sample included adults aged 18-64 years 
diagnosed with ≥ 1 CVD or associated comorbidity who reported having Medicaid 
coverage any time during survey year. Individuals with CVD having continuous, full-
year Medicaid coverage (N= 1,624) were compared to those with < 12 months of cov-
erage (N= 3,394). Medication adherence was calculated as proportion of days covered 
by refills of any CVD medication class examined during the reference period, capped 
at 1, and analyzed using ordinary least squares regression and multivariate logistic 
regression. Utilization of 5 CVD-specific health care resources – inpatient, emer-
gency (ER), outpatient, and office-based physician visits, and prescription medica-
tions – were estimated using zero-inflated negative binomial models controlling for 
sociodemographic, health status, disease burden, and Medicaid eligibility covariates, 
and year fixed effects. Results: Older age, White race, higher income, intermit-
tent employment, any private insurance were significant predictors of Medicaid 
discontinuity (P< 0.05). Individuals experiencing discontinuity in Medicaid coverage 
were predicted to have 0.03 more inpatient (P< 0.01), 0.03 more ER (P< 0.001), and 0.24 
less office-based physician visits (P< 0.05), and 0.02 more prescription medications 
(P< 0.05), all other things being equal. Medication adherence was not significantly 
different between the two groups, nor was it a significant predictor in most outcome 
models. ConClusions: Individuals with CVD having discontinuous Medicaid cov-
erage had higher hospital, and lower primary care utilization than their counterparts 
with continuous Medicaid coverage. Medicaid programs will greatly benefit from 
implementing provisions that mitigate coverage instability and associated disrup-
tions in continuity of care.
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objeCtives: Diabetic nephropathy is the leading cause of chronic kidney dis-
ease in the United States and is associated with increased mortality. A quality 
measure that contributes to a CMS Star Rating is that patients with hypertension 
and diabetes receive a renin-angiotensin system (RAS) inhibitor. The objective 
of this study was to compare the impact of a Diabetes Treatment Management 
(DTM) Program, aimed to improve the compliance of appropriate RAS inhibitors 
for diabetic patients, between dual eligible (DE) and non-DE Medicare Advantage 
beneficiaries. Methods: This was a retrospective study of pharmacy claims data 
among Medicare Advantage beneficiaries > 18 years of age in 2014. Members with 
one diabetic medication claim and one anti-hypertensive medication (calcium 
channel blockers or beta blockers) claim were included. The DTM program alerted 
the prescribing provider via fax to add a CMS recommended RAS inhibitor, if appro-
priate. Intervention success was defined when a recommended anti-hypertensive 
medication (renin angiotensin system antagonist, angiotensin converting enzyme, 
angiotensin receptor blocker, or direct renin inhibitor) was subsequently filled by 
the targeted member. Comparisons between groups were performed using the χ 2 
test. Results: This data represents 1,037,543 non-DE and 195,413 DE Medicare 
Advantage beneficiaries. A total of 32,154 members were eligible for the DTM 
program. Of these, 26,896 (84%) were among non-DE and 5,258 (16%) were among 
DE Medicare beneficiaries. The DTM program was successful in 26% of the overall 
population. The success rate was 27% (7,177/26,896) among non-DE compared 
to 23% (1,211/5,258) among DE Medicare beneficiaries receiving the intervention 
(p< 0.0001). ConClusions: The DTM program was more successful in the non-
DE than in the DE Medicare Advantage population. However, further research 
is needed to understand the factors behind the difference in success for these 
populations.
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objeCtives: The study aimed to compare the direct medical cost difference of 
hemorrhagic stroke inpatients with different types of health insurance from 2010 to 
2012 in China. Methods: A nationwide, cross-sectional sampling of hemorrhagic 
stroke inpatients with disease code ICD-10 (I60,I61,I62) with basic medical insurance 
scheme for employees (BMISE) and basic medical insurance scheme for urban resi-
dents (BMISUR) was extracted from the China Health Insurance Research Association 
claim database. A retrospective analysis was adopted. Results: The inpatients 
number of BMISE was 5321,the inpatients number of BMISUR was 1510. The average 
age was 63.08 and 62.34 years, respectively. Patients with BMISE went to third-level 
hospitals, second-level hospitals and under second-level hospitals accounted for 
57.01%, 33.71% and 9.27%; but for BMISUR, the percentage of distribution was 48.94%, 
